An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

Injury

Volumn 39, Issue 2, 2008, Pages 224-231

  Kwek, Ernest Beng Kee ^a   Goh, Seo Kiat ^a   Koh, Joyce Suang Bee ^a   Png, Meng Ai ^a   Howe, Tet Sen ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Alendronate; Insufficiency fractures; Prodromal symptoms; Severely suppressed bone turnover; Stress fractures; Stress reaction; Subtrochanteric femur fractures

Indexed keywords

ALENDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE RADIOGRAPHY; BONE TURNOVER; CLINICAL ARTICLE; FEMALE; FEMUR SUBTROCHANTERIC FRACTURE; HUMAN; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMORAL FRACTURES; FRACTURES, STRESS; HUMANS; INCIDENCE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PAIN; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 38749135807     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2007.08.036     Document Type: Article

References (17)

1. Armamento-Villareal R., Napoli N., Panwar V., and Novack D. Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355 19 (2006) 2048-2050
2. Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348 9041 (1996) 1535-1541
3. Black D.M., et al. Effects of continuing of stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA 296 24 (2006) 2968-2969
4. Butler J.E., Brown S.L., and McConnell B.G. Subtrochanteric stress fractures in runners. Am J Sports Med 10 4 (1982) 228-232
5. Currey J.D. Effects of differences in mineralization on the mechanical properties of bone. Phil Trans R Soc Lond Biol Sci 304 1121 (1984) 509-518
6. Esterberg J., Kassim R.A., Redmon J., et al. Hip pain in a case of hypophosphatemic osteomalacia. Am J Orthop 32 9 (2003 Sep) 455-458
7. Gaeta M., Minutoli F., Scribano E., et al. CT and MR imaging findings in athletes with early tibial stress injuries: comparison with bone scintigraphy findings and emphasis on cortical abnormalities. Radiology 235 2 (2005) 553-561
8. Goh S.K., Yang K.Y., Koh J.S., et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 89 3 (2007 Mar) 349-353
9. Leinberry C.F., McShane R.B., Stewart Jr. W.G., and Hume E.L. A displaced subtrochanteric stress fracture in a young amenorrheic athlete. Am J Sports Med 20 4 (1992) 485-487
10. Mashiba T., Mori S., Burr D.B., et al. The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23 Suppl. (2005) 36-42
11. Odvina C.V., Zerwekh J.E., Rao D.S., et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90 3 (2005) 1294-1301
12. Ott S.M. Fractures after long-term alendronate therapy. J Clin Endocrinol Metab 85 9 (2000) 3109-3115
13. Ott S.M. Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90 3 (2005) 1897-1899
14. Roth V.G. Pycnodysostosis presenting with bilateral subtrochanteric fractures: case report. Clin Orthop Relat Res 117 (1976) 247-253
15. Schneider J.P. Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriartrics 61 1 (2006) 31-33
16. Schnitzler C.M., Wing J.R., Gear K.A., and Robson H.J. Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis. Clin Orthop Relat Res 261 (1990) 268-275
17. Wasserman N., Yerramshetty J., and Akkus O. Microcracks colocalize within highly mineralized regions of cortical bone tissue. Eur J Morphol 42 1/2 (2005) 43-51